These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 15461548

  • 21. Efficacy and safety of topically applied tacrolimus ointment in patients with moderate to severe atopic dermatitis.
    Wong WR, Tsai HJ, Hong HS.
    Chang Gung Med J; 2003 Jul; 26(7):485-95. PubMed ID: 14515971
    [Abstract] [Full Text] [Related]

  • 22. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.
    Czarnecka-Operacz M, Jenerowicz D.
    J Dtsch Dermatol Ges; 2012 Mar; 10(3):167-72. PubMed ID: 21974750
    [Abstract] [Full Text] [Related]

  • 23. The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis.
    McCollum AD, Paik A, Eichenfield LF.
    Pediatr Dermatol; 2010 Mar; 27(5):425-36. PubMed ID: 20678096
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K, Werfel T, Kapp A.
    Am J Clin Dermatol; 2005 Mar; 6(2):65-77. PubMed ID: 15799678
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pimecrolimus in dermatology: atopic dermatitis and beyond.
    Gisondi P, Ellis CN, Girolomoni G.
    Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
    [Abstract] [Full Text] [Related]

  • 28. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA.
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [Abstract] [Full Text] [Related]

  • 29. Topical tacrolimus: a new therapy for atopic dermatitis.
    Russell JJ.
    Am Fam Physician; 2002 Nov 15; 66(10):1899-902. PubMed ID: 12469964
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Off-label Uses of Topical Pimecrolimus.
    Ladda M, Sandhu V, Ighani A, Yeung J.
    J Cutan Med Surg; 2019 Nov 15; 23(4):442-448. PubMed ID: 31053034
    [Abstract] [Full Text] [Related]

  • 32. [Long term management of childhood atopic dermatitis with calcineurin inhibitors].
    Thaçi D.
    Hautarzt; 2003 May 15; 54(5):418-23. PubMed ID: 12719861
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Safety and efficacy of tacrolimus ointment 0.1% (Protopic) in atopic dermatitis: a Canadian open-label multicenter study.
    Tan J, Langley R.
    J Cutan Med Surg; 2004 May 15; 8(4):213-9. PubMed ID: 16091997
    [Abstract] [Full Text] [Related]

  • 37. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA, Lamerson C, Sheehan MP, Boguniewicz M, Mosser J, Raimer S, Shull T, Jaracz E, US Tacrolimus Ointment Study Group.
    Pediatrics; 2005 Sep 15; 116(3):e334-42. PubMed ID: 16140675
    [Abstract] [Full Text] [Related]

  • 38. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.
    Chen SL, Yan J, Wang FS.
    J Dermatolog Treat; 2010 May 15; 21(3):144-56. PubMed ID: 20394490
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Potential future dermatological indications for tacrolimus ointment.
    Ruzicka T, Assmann T, Lebwohl M.
    Eur J Dermatol; 2003 May 15; 13(4):331-42. PubMed ID: 12948911
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.